Biomerica (BMRA) Stock: Why It's Down Today
Updated Oct 19, 2026, 12:35 PM ET · intraday price
- Trading at $1.79 as of 12:35 PM ET, -2.97% vs the prior close of $1.85.
- Volume 12.18K shares, 0.1x its 50-day average (light).
- New SEC filings: DEF 14A (Oct 16, 2026).
- No new insider buys or sales reported since the prior session.
BMRA dips 3.0% to $1.79, a 1-month low. Trading at $1.79 (intraday, 12:35 PM ET), -2.97% vs the prior close of $1.85. Day range $1.75–$1.85, opened at $1.85.
BMRA daily analysis — what happened
A plain-English, data-only note for every US trading day (today's note updates every 2 hours while the market is open). Newest first; older days stay archived below.
Oct 19, 2026 — BMRA dips 3.0% to $1.79, a 1-month low
- Trading at $1.79 (intraday, 12:35 PM ET), -2.97% vs the prior close of $1.85. Day range $1.75–$1.85, opened at $1.85.
- Volume was 12.18K shares, 0.1x its 50-day average of 89.54K — lighter than usual.
- Price is -12.1% vs its 50-day average ($2.04) and -14.2% vs its 200-day average ($2.09).
- 52-week range $1.45–$3.21; the current price sits at 20% of that range, 44.1% below the 52-week high.
Oct 16, 2026 — BMRA dips 1.6% to $1.85
- Closed at $1.85, -1.60% vs the prior close of $1.88. Day range $1.81–$1.95, opened at $1.83.
- Volume was 13.19K shares, 0.1x its 50-day average of 89.37K — lighter than usual.
- Price is -9.2% vs its 50-day average ($2.04) and -11.8% vs its 200-day average ($2.10).
- 52-week range $1.45–$3.21; today's close sits at 23% of that range, 42.4% below the 52-week high.
Oct 15, 2026 — BMRA jumps 4.4% to $1.88
- Closed at $1.88, +4.44% vs the prior close of $1.80. Day range $1.81–$1.92, opened at $1.87.
- Volume was 13.80K shares, 0.2x its 50-day average of 89.12K — lighter than usual.
- Price is -7.5% vs its 50-day average ($2.03) and -10.5% vs its 200-day average ($2.10).
- 52-week range $1.45–$3.21; today's close sits at 24% of that range, 41.4% below the 52-week high.
- SEC filings that day: 10-Q, 8-K.
Oct 14, 2026 — BMRA dips 2.7% to $1.80, a 1-month low
- Closed at $1.80, -2.70% vs the prior close of $1.85. Day range $1.76–$1.86, opened at $1.83.
- Volume was 18.60K shares, 0.2x its 50-day average of 89.04K — lighter than usual.
- Price is -11.2% vs its 50-day average ($2.03) and -14.4% vs its 200-day average ($2.10).
- 52-week range $1.45–$3.21; today's close sits at 20% of that range, 43.9% below the 52-week high.
Oct 13, 2026 — BMRA rises 0.5% to $1.85
- Closed at $1.85, +0.54% vs the prior close of $1.84. Day range $1.81–$1.89, opened at $1.85.
- Volume was 13.30K shares, 0.1x its 50-day average of 88.91K — lighter than usual.
- Price is -8.5% vs its 50-day average ($2.02) and -12.2% vs its 200-day average ($2.11).
- 52-week range $1.45–$3.21; today's close sits at 23% of that range, 42.4% below the 52-week high.
Oct 12, 2026 — BMRA ends flat (+0.0%) to $1.84, 4 down days in a row
- Closed at $1.84, +0.00% vs the prior close of $1.84. Day range $1.84–$1.90, opened at $1.90.
- Volume was 4.90K shares, 0.1x its 50-day average of 89.04K — lighter than usual.
- Price is -8.7% vs its 50-day average ($2.02) and -12.9% vs its 200-day average ($2.11).
- 52-week range $1.45–$3.21; today's close sits at 22% of that range, 42.7% below the 52-week high.
- That makes 4 straight losses.
Oct 9, 2026 — BMRA dips 2.6% to $1.84, a 1-month low, 3 down days in a row
- Closed at $1.84, -2.65% vs the prior close of $1.89. Day range $1.84–$1.87, opened at $1.86.
- Volume was 10.30K shares, 0.1x its 50-day average of 89.05K — lighter than usual.
- Price is -8.4% vs its 50-day average ($2.01) and -13.0% vs its 200-day average ($2.12).
- 52-week range $1.45–$3.21; today's close sits at 22% of that range, 42.7% below the 52-week high.
- That makes 3 straight losses.
Oct 8, 2026 — BMRA dips 1.0% to $1.89, a 1-month low
- Closed at $1.89, -1.05% vs the prior close of $1.91. Day range $1.86–$1.91, opened at $1.91.
- Volume was 6.60K shares, 0.1x its 50-day average of 89.13K — lighter than usual.
- Price is -5.7% vs its 50-day average ($2.00) and -10.8% vs its 200-day average ($2.12).
- 52-week range $1.45–$3.21; today's close sits at 25% of that range, 41.1% below the 52-week high.
Oct 7, 2026 — BMRA slides 10.7% to $1.91, a 1-month low
- Closed at $1.91, -10.75% vs the prior close of $2.14. Day range $1.90–$2.10, opened at $2.10.
- Volume was 34.70K shares, 0.4x its 50-day average of 88.52K — lighter than usual.
- Price is -4.4% vs its 50-day average ($2.00) and -9.9% vs its 200-day average ($2.12).
- 52-week range $1.45–$3.21; today's close sits at 26% of that range, 40.5% below the 52-week high.
Oct 6, 2026 — BMRA jumps 4.4% to $2.14
- Closed at $2.14, +4.39% vs the prior close of $2.05. Day range $2.01–$2.14, opened at $2.09.
- Volume was 11.10K shares, 0.1x its 50-day average of 88.36K — lighter than usual.
- Price is +7.5% vs its 50-day average ($1.99) and +0.8% vs its 200-day average ($2.12).
- 52-week range $1.45–$3.21; today's close sits at 39% of that range, 33.3% below the 52-week high.
Oct 5, 2026 — BMRA slides 4.2% to $2.05, a 1-month low, 5 down days in a row
- Closed at $2.05, -4.21% vs the prior close of $2.14. Day range $2.02–$2.19, opened at $2.06.
- Volume was 33.90K shares, 0.4x its 50-day average of 88.03K — lighter than usual.
- Price is +3.5% vs its 50-day average ($1.98) and -3.5% vs its 200-day average ($2.12).
- 52-week range $1.45–$3.21; today's close sits at 34% of that range, 36.1% below the 52-week high.
- That makes 5 straight losses.
Oct 2, 2026 — BMRA slides 4.5% to $2.14, a 1-month low, 4 down days in a row
- Closed at $2.14, -4.46% vs the prior close of $2.24. Day range $2.14–$2.23, opened at $2.19.
- Volume was 8.40K shares, 0.1x its 50-day average of 87.91K — lighter than usual.
- Price is +8.5% vs its 50-day average ($1.97) and +0.7% vs its 200-day average ($2.13).
- 52-week range $1.45–$3.21; today's close sits at 39% of that range, 33.3% below the 52-week high.
- That makes 4 straight losses.
BMRA bull case vs bear case (from the data)
- Insiders made 20 open-market purchases in the last 12 months.
- Price is -12.1% vs its 50-day average — short-term trend is down.
- Price is -14.2% vs its 200-day average — below the long-term trend line.
- Annual revenue fell 16.2% in the latest fiscal year (SEC XBRL).
- Latest fiscal-year net income: loss of $3.77M.
- Share count up 60.2% in a year (dilution).
- High volatility: average daily move of 3.7% over 20 sessions.
- Thin trading (under $2M a day on average) can mean wide bid/ask spreads.
BMRA latest news & SEC filings
Every SEC filing by or about BMRA in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 16, 2026 · Form DEF 14A — Proxy statement
Proxy statement — agenda for the shareholder meeting (board elections, executive pay, votes)
Oct 15, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Aug 31, 2026:
- Revenue: $1.26M (prior year $1.38M) (-8.3% vs Aug 31, 2025)
- Net income: -$1.23M (prior year $2.00K) (loss widened vs Aug 31, 2025)
- Diluted EPS: -$0.37 (prior year $0.00)
Oct 15, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
Sep 28, 2026 · Form 10-K/A — Annual report (amended)
Amended annual report
Key figures from this report aren't in the SEC's structured data yet (usually appears within a day or two).
Sep 24, 2026 · Form S-3 — Shelf registration (S-3)
Shelf registration (S-3) — lets the company sell securities over time
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Sep 24, 2026 · Form S-3 — Shelf registration (S-3)
Shelf registration (S-3) — lets the company sell securities over time
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Sep 10, 2026 · Form 3 — New insider holdings
Initial insider ownership statement (Form 3) — a new director, officer or 10% owner disclosed their holdings
Sep 8, 2026 · Form 3 — New insider holdings
Initial insider ownership statement (Form 3) — a new director, officer or 10% owner disclosed their holdings
Aug 31, 2026 · Form 10-K — Annual report
Annual report (audited full-year financial statements and business review)
Fiscal year ended May 31, 2026:
- Revenue: $4.45M (prior year $5.31M) (-16.2% vs May 31, 2025)
- Net income: -$3.77M (prior year -$4.97M) (loss narrowed vs May 31, 2025)
- Diluted EPS: -$1.30 (prior year -$2.16) (loss narrowed vs May 31, 2025)
Aug 28, 2026 · Form SCHEDULE 13D — Activist-style stake (13D)
Activist-style stake (13D) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 27, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Gary M. Huff bought 31,250 shares at $1.60 (≈$50.00K) on Aug 20, 2026
- Gary M. Huff bought 31,250 shares at $1.60 (≈$50.00K) on Aug 20, 2026
- Gary M. Huff bought 31,250 shares at $1.60 (≈$50.00K) on Aug 20, 2026
- Gary M. Huff bought 31,250 shares at $1.60 (≈$50.00K) on Aug 20, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 27, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Moatazedi David bought 10,000 shares at $1.60 (≈$16.00K) on Aug 26, 2026
- Moatazedi David bought 10,000 shares at $1.60 (≈$16.00K) on Aug 26, 2026
- Moatazedi David bought 10,000 shares at $1.60 (≈$16.00K) on Aug 26, 2026
- Moatazedi David bought 10,000 shares at $1.60 (≈$16.00K) on Aug 26, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 27, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Chin Eric bought 6,250 shares at $1.60 (≈$10.00K) on Aug 26, 2026
- Chin Eric bought 6,250 shares at $1.60 (≈$10.00K) on Aug 26, 2026
- Chin Eric bought 6,250 shares at $1.60 (≈$10.00K) on Aug 26, 2026
- Chin Eric bought 6,250 shares at $1.60 (≈$10.00K) on Aug 26, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Things to know before you trade BMRA
- Last results release: Dec 16, 2021 (8-K Item 2.02).
- How much it moves: over the last 20 sessions the average daily move was 3.68% (largest 10.7%). That is a volatile stock.
- Liquidity: about 19.67K shares (≈$35.31K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $1.79 vs a range of $1.45–$3.21 (20% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: 1:8 on Apr 21, 2025
- Insider trades (Form 4, last 12 months, recent 25 shown): 20 open-market buys, 0 sales; latest: Eric Chin bought 6,250 shares on Aug 26, 2026.
- Latest filings: 10-Q Oct 15, 2026; 8-K Oct 15, 2026; 10-K Aug 31, 2026.
- Share count: 4.60M shares outstanding (Oct 15, 2026), +60.2% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: In Vitro & In Vivo Diagnostic Substances.
BMRA market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 19, 2026 | 1.85 | 1.85 | 1.75 | 1.79 | 12.18K |
| Oct 16, 2026 | 1.83 | 1.95 | 1.81 | 1.85 | 13.20K |
| Oct 15, 2026 | 1.87 | 1.92 | 1.81 | 1.88 | 13.80K |
| Oct 14, 2026 | 1.83 | 1.86 | 1.76 | 1.80 | 18.60K |
| Oct 13, 2026 | 1.85 | 1.89 | 1.81 | 1.85 | 13.30K |
| Oct 12, 2026 | 1.90 | 1.90 | 1.84 | 1.84 | 4.90K |
| Oct 9, 2026 | 1.86 | 1.87 | 1.84 | 1.84 | 10.30K |
| Oct 8, 2026 | 1.91 | 1.91 | 1.86 | 1.89 | 6.60K |
| Oct 7, 2026 | 2.10 | 2.10 | 1.90 | 1.91 | 34.70K |
| Oct 6, 2026 | 2.09 | 2.14 | 2.01 | 2.14 | 11.10K |
| Oct 5, 2026 | 2.06 | 2.19 | 2.02 | 2.05 | 33.90K |
| Oct 2, 2026 | 2.19 | 2.23 | 2.14 | 2.14 | 8.40K |
| Oct 1, 2026 | 2.25 | 2.25 | 2.24 | 2.24 | 2.20K |
| Sep 30, 2026 | 2.32 | 2.34 | 2.25 | 2.26 | 11.40K |
| Sep 29, 2026 | 2.35 | 2.35 | 2.30 | 2.30 | 2.50K |
| Sep 28, 2026 | 2.30 | 2.39 | 2.29 | 2.39 | 7.10K |
| Sep 25, 2026 | 2.43 | 2.64 | 2.18 | 2.32 | 58.60K |
| Sep 24, 2026 | 2.60 | 2.64 | 2.44 | 2.46 | 51.00K |
| Sep 23, 2026 | 2.79 | 2.84 | 2.58 | 2.61 | 37.60K |
| Sep 22, 2026 | 2.60 | 2.78 | 2.57 | 2.78 | 42.00K |
About Biomerica
Biomerica (BMRA) is listed on the Nasdaq and classified by the SEC under “In Vitro & In Vivo Diagnostic Substances”. Its business address is in IRVINE, CA. State of incorporation: DE. Fiscal year ends May 31. SEC CIK 73290.
BMRA board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Allen Barbieri | Executive Vice Chairman | Aug 27, 2026 |
| Eric Chin | Director | Aug 27, 2026 |
| M. Huff Gary | Director | Aug 27, 2026 |
| Zackary S. Irani | Chief Executive Officer | Aug 27, 2026 |
| David Moatazedi | Director | Aug 27, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Allen Barbieri | Executive Vice Chairman | Aug 27, 2026 |
| Zackary S. Irani | Chief Executive Officer | Aug 27, 2026 |
| Gary Lu | Chief Financial Officer | Dec 31, 2025 |
| Xiaoxuan Qu | See Remarks | Sep 8, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Aug 26, 2026 | Eric Chin | Buy | 6,250 | $1.60 |
| Aug 26, 2026 | Eric Chin | Buy | 6,250 | $1.60 |
| Aug 26, 2026 | Eric Chin | Buy | 6,250 | $1.60 |
| Aug 26, 2026 | Eric Chin | Buy | 6,250 | $1.60 |
| Aug 26, 2026 | Allen Barbieri | Buy | 20,000 | $1.60 |
| Aug 26, 2026 | Allen Barbieri | Buy | 20,000 | $1.60 |
| Aug 26, 2026 | Allen Barbieri | Buy | 20,000 | $1.60 |
| Aug 26, 2026 | Allen Barbieri | Buy | 20,000 | $1.60 |
| Aug 26, 2026 | David Moatazedi | Buy | 10,000 | $1.60 |
| Aug 26, 2026 | David Moatazedi | Buy | 10,000 | $1.60 |
| Aug 26, 2026 | David Moatazedi | Buy | 10,000 | $1.60 |
| Aug 26, 2026 | David Moatazedi | Buy | 10,000 | $1.60 |
| Aug 26, 2026 | Zackary S. Irani | Buy | 31,250 | $1.60 |
| Aug 26, 2026 | Zackary S. Irani | Buy | 31,250 | $1.60 |
| Aug 26, 2026 | Zackary S. Irani | Buy | 31,250 | $1.60 |
BMRA financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| May 31, 2026 | $4.45M | $-3.77M | -1.30 | $-3.42M |
| May 31, 2025 | $5.31M | $-4.97M | -2.16 | $-3.84M |
| May 31, 2024 | $5.42M | $-5.98M | -2.84 | $-5.36M |
| May 31, 2023 | $5.34M | $-7.14M | -0.50 | $-5.47M |
| May 31, 2022 | $18.87M | $-4.53M | -0.36 | $-479.00K |
Latest balance sheet: total assets $8.07M, total liabilities $4.42M, cash $2.73M (as of Aug 31, 2026).
BMRA earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Dec 16, 2021 | 8-K Item 2.02 (results) | — |
Related stocks · In Vitro & In Vivo Diagnostic Substances
Idexx Laboratories (IDXX)Lantheus (LNTH)Celldex Therapeutics (CLDX)Intellia Therapeutics (NTLA)Neogen (NEOG)QuidelOrtho (QDEL)Achieve Life Sciences (ACHV)Myriad Genetics (MYGN)Alpha Teknova (TKNO)Q/C Technologies (QCLS)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)AMD (AMD)Microsoft (MSFT)Intel (INTC)Amazon (AMZN)
More on BMRA
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: intraday data as of Oct 19, 2026, 12:35 PM ET. Filings: SEC EDGAR. Refreshed every 2 hours during US market hours.